Xiaoqing Fu
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies 15
- Antimicrobial Resistance in Staphylococcus 11
- Immunology and Allergy top 5%
- Rheumatology top 5%
- IgG4-Related and Inflammatory Diseases 8
- Dermatology top 5%
- Pharmacology top 5%
- Drug-Induced Adverse Reactions 16
-
- Vasculitis and related conditions 14
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 10
-
- Long-Term Effects of COVID-19 9
-
- Analytical Chemistry and Chromatography 7
- Co-authors
- Zachary S. WallaceHyon K. ChoiKimberly G. BlumenthalJohn H. StoneYuqing ZhangJeffrey A. SparksRachel WallworkTiffany Hsu
- Partner nations
- United StatesChinaGermany
In The Last Decade
Xiaoqing Fu
134 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 149
- Infectious Diseases 656
- Immunology and Allergy 163
- Rheumatology 305
- Dermatology 159
- Pharmacology 278
Countries citing papers authored by Xiaoqing Fu
This map shows the geographic impact of Xiaoqing Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoqing Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoqing Fu more than expected).
Fields of papers citing papers by Xiaoqing Fu
This network shows the impact of papers produced by Xiaoqing Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoqing Fu. The network helps show where Xiaoqing Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoqing Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 14 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 27 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 28 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 52 | |
| 11 | 2020 | 2 | |
| 12 | 2020 | 20 | |
| 13 | 2019 | 3 | |
| 14 | 2019 | 21 | |
| 15 | 2018 | 26 | |
| 16 | 2018 | 14 | |
| 17 | 2018 | 32 | |
| 18 | 2014 | 21 | |
| 19 | 2013 | 19 | |
| 20 | 2012 | 44 |
About Xiaoqing Fu
Xiaoqing Fu is a scholar working on Infectious Diseases, Toxicology and Immunology and Allergy, having authored 140 papers that have together received 2.3k indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (16 papers), COVID-19 Clinical Research Studies (15 papers), Vasculitis and related conditions (14 papers), Antimicrobial Resistance in Staphylococcus (11 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers), Long-Term Effects of COVID-19 (9 papers), IgG4-Related and Inflammatory Diseases (8 papers) and Analytical Chemistry and Chromatography (7 papers). The work is most often cited by research in Infectious Diseases (656 citations), Immunology and Allergy (163 citations) and Rheumatology (305 citations). Xiaoqing Fu has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Zachary S. Wallace, Hyon K. Choi, Kimberly G. Blumenthal, John H. Stone, Yuqing Zhang, Jeffrey A. Sparks, Rachel Wallwork, Tiffany Hsu, Kristin M. D’Silva and Michael Lämmerhofer. Their work appears in journals such as Nucleic Acids Research, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.